Industry Overview

North American Medical Grade Silicone Market was valued at $837.4 million in 2025 and is projected to reach $1,691.8 million by 2035, growing at a CAGR of 7.4% during the forecast period (2026–2035). The North American market is expanding steadily, supported by sustained investment in healthcare infrastructure and continuous innovation in medical technologies. Strong demand for high-performance and biocompatible materials across regulated applications is reinforcing material adoption. Manufacturers are increasingly focused on meeting stringent quality and compliance requirements, which favors the use of certified specialty materials. Growth is further supported by the presence of advanced medical device manufacturing and long product replacement cycles. Ongoing improvements in material processing and formulation are enhancing performance reliability. Together, these factors are contributing to consistent market development throughout the forecast period.

Market Dynamics

Rising Demand for Advanced Biocompatible Materials

The global market is witnessing increased adoption of advanced biocompatible materials across a wide range of healthcare applications. Manufacturers are prioritizing materials that offer long-term stability, safety, and compatibility with human tissue. This shift is strengthening demand from regulated medical sectors that require consistent performance over extended product lifecycles. Continuous improvements in material purity and processing standards are further supporting this trend. As healthcare technologies evolve, material selection is becoming a critical factor in product differentiation. These developments are contributing to steady market expansion worldwide.

Expansion of Medical Manufacturing and Supply Chain Localization

The market is also influenced by the gradual expansion of medical manufacturing capabilities across multiple regions. Companies are investing in localized production and supply chains to improve reliability and regulatory alignment. This approach supports faster product development and greater control over quality standards. Increased regional manufacturing activity is driving demand for certified materials across both mature and emerging markets. Over time, this trend is expected to support balanced growth across global regions.

Market Segmentation

• Based on the form, the market is segmented into gels, medical adhesives, medical coatings, and elastomers.
• Based on the application, the market is segmented into medical devices, medical tapes, oral care, prosthetics & orthopedic, contact lenses, and others.

Elastomers Segment to Lead the Market with the Largest Share

Elastomers represent one of the leading sub-segments due to their extensive use in both implantable and non-implantable medical applications. Their flexibility, durability, and resistance to extreme conditions make them suitable for components such as tubing, seals, catheters, and implant housings. Consistent performance under sterilization and long-term use supports widespread adoption. Ongoing advancements in processing technologies are improving precision and material consistency. This sub-segment continues to account for a significant share of overall demand.

Medical Devices: A Key Segment in Market Growth

The medical devices sub-segment holds a leading position, driven by the continuous development of diagnostic, therapeutic, and implantable solutions. Materials used in this segment must meet strict safety, performance, and regulatory standards, supporting demand for specialized material grades. Growing adoption of minimally invasive procedures and long-term treatment devices is reinforcing material consumption. Stable replacement cycles and expanding healthcare access further contribute to sustained growth. This segment remains a key driver of market expansion.

Regional Outlook

The North American Medical Grade Silicone Market is further divided by countries, including the US and Canada.

US Dominates the Market with Major Share

The US dominates the North American medical-grade silicone market due to several key factors. It hosts a dense concentration of medical device manufacturers, ranging from large multinational corporations to specialized startups, which drives continuous demand for high-performance and biocompatible materials. The U.S. healthcare system emphasizes advanced treatment solutions, including implantable devices, minimally invasive surgical tools, and diagnostic equipment, all of which rely heavily on medical-grade silicone for durability, flexibility, and regulatory compliance. Furthermore, stringent FDA regulations ensure that only high-quality, certified materials are used, encouraging manufacturers to source premium silicone products. Strong R&D investments in medical technology, coupled with high healthcare expenditure, also stimulate innovation and adoption of new silicone formulations. In addition, well-established supply chains, domestic manufacturing facilities, and a robust regulatory framework contribute to the United States maintaining a dominant position in the regional market.

Market Players Outlook

The major companies operating in the North America medical grade silicone market include 3M Company, Avantor, Inc., Dow Inc., DuPont de Nemours, Inc., and Rogers Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In July 2023, Sientra, distributed by Clarion Medical Technologies, launched its High-Strength Cohesive Silicone Gel Breast Implants in Canada, marking the first new silicone gel implant approval by Health Canada in nearly 20 years. The implants feature advanced generational gel technology with clinically proven low complication rates and are available exclusively through board-certified plastic surgeons, enhancing patient safety. The launch is supported by the Sientra Platinum20™ Warranty Program, recognized as the most comprehensive in the industry. This introduction provides Canadian clinicians with an additional high-quality option in the breast implant segment, expanding material and device choices in the medical-grade silicone market.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North American Medical Grade Silicone Market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.